SEC Form 6-K Summary
Business Context and Reporting Period
Concord Medical Services Holdings Limited filed this Form 6-K for September 2026. The filing concerns a change in independent auditor, non-reliance on previously issued financial statements, and the planned restatement of the Company’s consolidated financial statements for the years ended December 31, 2024 and 2025.
Financial Metrics and Liquidity
The filing does not provide updated revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics. The prior audit reports included an explanatory paragraph regarding the Company’s ability to continue as a going concern.
The filing identifies a material weakness related to insufficient accounting staff and resources with appropriate knowledge of U.S. GAAP, SEC reporting, and compliance.
Material Changes Versus Prior Period
- Shandong Haoxin Certified Public Accountants Co., Ltd. resigned as independent registered public accounting firm on September 14, 2026.
- Guangdong Prouden CPAs GP was engaged as the new independent registered public accounting firm on September 22, 2026, with audit committee approval.
- The Company determined that its previously issued audited consolidated financial statements for 2024 and 2025 should no longer be relied upon.
- The Company intends to deconsolidate Concord Healthcare Group Co., Ltd. effective in 2024 and restate the affected financial information.
The SEC Staff stated that the Company lost its controlling financial interest in CHG when its voting interest declined below a majority in 2024. The requested accounting treatment references ASC 810-10-15-10, ASC 810-10-25-1, and Article 3A-02 of Regulation S-X.
Outlook, Risks, and Unusual Items
The Company intends to amend its 2025 Form 20-F to include restated consolidated financial statements for 2024 and 2025. The filing does not provide a clear expected filing date.
Risks include the time required to complete the restatement, completion of audit and review procedures, identification of additional accounting errors or adjustments, changes in accounting or regulatory requirements, and the Company’s ability to file the amended Form 20-F within the expected timeframe. Actual timing and results may differ materially from current expectations.
Management reported no disagreements with the former auditor regarding accounting principles, financial statement disclosure, or audit scope or procedures. No reportable events were identified other than the material weakness and the non-reliance on previously issued financial statements.
Key Facts for Investor Verification
- Confirm the scope and dollar impact of the CHG deconsolidation on 2024 and 2025 revenue, assets, liabilities, earnings, and cash flows.
- Monitor the amended 2025 Form 20-F and the restated financial statements.
- Assess whether the restatement identifies additional accounting errors or adjustments.
- Evaluate the Company’s going-concern status, liquidity, and financing needs after restatement.
- Review Guangdong Prouden’s audit reports and any updated internal-control disclosures.
- Verify the timing and completion of the new audit and SEC filing process.